Restart Life Sciences Corp. (NMLSF)
| Market Cap | 4.19M +158.2% |
| Revenue (ttm) | n/a |
| Net Income | -885.27K |
| EPS | -0.03 |
| Shares Out | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 200 |
| Average Volume | 5,664 |
| Open | 0.0822 |
| Previous Close | 0.0822 |
| Day's Range | 0.0822 - 0.0822 |
| 52-Week Range | 0.0300 - 0.1020 |
| Beta | -1.02 |
| RSI | 51.39 |
| Earnings Date | Apr 8, 2026 |
About Restart Life Sciences
Restart Life Sciences Corp., through its subsidiaries, operates as a biotechnology company worldwide. It engages in developing natural remedies specifically tailored for individuals on the autism spectrum; health-related foods that promote both mind and body wellness for healthy living, as well as psilocybin clinical trial for fragile X syndrome. The company was formerly known as Nova Mentis Life Science Corp. and changed its name to Restart Life Sciences Corp. in November 2024. Restart Life Sciences Corp. was incorporated in 2004 and is based ... [Read more]
News
Restart Life Receives Aggregate Gross Proceeds of Approximately $590,000 from Warrant Exercises and Loan
Vancouver, British Columbia--(Newsfile Corp. - December 22, 2025) - Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSF) ("Restart Life" or the "Company") is pleased to announce that ...
Restart Life Sciences Signs Binding LOI to Acquire The Holy Crap Foods Portfolio of Brands and Manufacturing Plant
Vancouver, British Columbia--(Newsfile Corp. - December 22, 2025) - Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSF) ("Restart" or the "Company") is pleased to announce that it ha...
Restart Life Closes Over-Subscribed Second Tranche Financing
Vancouver, British Columbia--(Newsfile Corp. - December 18, 2025) - Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSF) ("Restart Life" or the "Company") announces that further to it...
Restart Life Announces Food Technology and Research Studies
Vancouver, British Columbia--(Newsfile Corp. - December 17, 2025) - Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSF) ("Restart Life" or the "Company") is pleased to provide an upd...
Restart Life Sciences Announces Closing First Tranche of Financing
Vancouver, British Columbia--(Newsfile Corp. - December 5, 2025) - Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSF) ("Restart Life" or the "Company") announces that further to its...
Restart Life Sciences Announces Private Placement Financing
Vancouver, British Columbia--(Newsfile Corp. - November 12, 2025) - Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSF) ("Restart Life" or the "Company") is pleased to announce a non...
Restart Life Sciences Provides Corporate Update on Strategy and Growth Initiatives
Vancouver, British Columbia--(Newsfile Corp. - August 21, 2025) - Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSF) ("Restart Life" or the "Company") today announced that it has el...
Restart Life Announces $1,000,000 LIFE Financing
Vancouver, British Columbia--(Newsfile Corp. - July 8, 2025) - Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSF) ("Restart Life" or the "Company") is pleased to announce a non-brok...
Restart Life Introduces BrainQ(TM) - A Wholly Owned Brand
Vancouver, British Columbia--(Newsfile Corp. - June 11, 2025) - Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSF) ("Restart Life" or the "Company") is pleased to introduce BrainQ™,...
Restart Life Introduces BrainBalls(TM) Product Line
Vancouver, British Columbia--(Newsfile Corp. - June 5, 2025) - Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSF) ("Restart Life" or the "Company") is pleased to announce the forthc...
Restart Life Expands Intellectual Property Through Trademark Licensing Agreement
Vancouver, British Columbia--(Newsfile Corp. - March 17, 2025) - Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSD) ("Restart Life" or the "Company") is pleased to announce that it ...
Restart Life Secures Strategic Production Partner
Vancouver, British Columbia--(Newsfile Corp. - February 19, 2025) - Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSD) ("Restart Life" or the "Company") is pleased to announce that ...
Restart Life Announces Key Business Updates
Vancouver, British Columbia--(Newsfile Corp. - February 13, 2025) - Restart Life Science Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSD) ("Restart Life" or the "Company") is pleased to provide an upda...
Restart Life Sciences Corp. Relies on Exception Under CSE Policy 4.6(2)(b) for Previously Closed Private Placement and Debt Settlement Transactions and Announces Debt Settlement Transaction
Vancouver, British Columbia--(Newsfile Corp. - February 7, 2025) - Restart Life Science Corp. (CSE: HEAL) (FSE: HN3) (OTC Pink: NMLSD) ("Restart Life" or the "Company") announces that the Company prop...
Nova Mentis Assigns Intellectual Property
Vancouver, British Columbia--(Newsfile Corp. - August 27, 2024) - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) ("NOVA" or the "Company") is pleased to announce it has entered ...
CSE Bulletin: WITHDRAWN - Symbol Change - Inactive Designation - Nova Mentis Life Science Corp. (NOVA)
Toronto, Ontario--(Newsfile Corp. - le 8 août/August 2024) - Bulletin 2024-0809 - Symbol Change - Inactive Designation - Nova Mentis Life Science Corp. (NOVA) has been withdrawn. If you have any quest...
CSE Bulletin: Symbol Change - Inactive Designation - Nova Mentis Life Science Corp. (NOVA)
Toronto, Ontario--(Newsfile Corp. - Le 8 août/August 2024) - The Exchange has determined that Nova Mentis Life Science Corp. (the “Issuer”) has not met the continued listing requirements as set out in...
Nova Mentis Announces Change of Directors
Vancouver, British Columbia--(Newsfile Corp. - February 26, 2024) - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) ("NOVA" or the "Company") announces the appointment of Steve L...
Nova Mentis Applauds Government Decision to Create Rare Disease Advisory Group
Vancouver, British Columbia--(Newsfile Corp. - November 3, 2023) - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) ("NOVA" or the "Company"), a biotechnology company and global l...
Nova Mentis Announces Participant Screening Underway in Canada's First Psilocybin Clinical Trial for Fragile X Syndrome
Vancouver, British Columbia--(Newsfile Corp. - August 30, 2023) - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) ("NOVA" or the "Company"), a biotechnology company and global le...
Nova Mentis to Enter mRNA AI Diagnostics Business
Vancouver, British Columbia--(Newsfile Corp. - April 26, 2023) - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) ("NOVA" or the "Company"), a biotechnology company and global lea...
Nova Mentis Begins Recruitment in First-of-its-Kind Health Canada Psilocybin Trial
Vancouver, British Columbia--(Newsfile Corp. - April 18, 2023) - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) ("NOVA" or the "Company"), a biotechnology company and global lea...
Nova Mentis Receives Institutional Review Board Approval to Commence Psilocybin Clinical Trial
Vancouver, British Columbia--(Newsfile Corp. - April 11, 2023) - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) ("NOVA" or the "Company"), a biotechnology company and global lea...
Nova Mentis Provides Corporate Update and 2023 Outlook
Vancouver, British Columbia--(Newsfile Corp. - April 5, 2023) - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) ("NOVA" or the "Company"), a biotechnology company and global lead...
Novel Therapeutic Solutions are Needed as Autism Rates Increase
Vancouver, British Columbia--(Newsfile Corp. - March 29, 2023) - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF) ("NOVA" or the "Company"), a biotechnology company and global lea...